Sara Rockwell Selected Research

Sara Rockwell Research Topics

Disease

25	Neoplasms (Cancer) 12/2017 - 08/2002
13	Hypoxia (Hypoxemia) 12/2017 - 08/2002
3	Breast Neoplasms (Breast Cancer) 01/2013 - 04/2005
2	Neoplasm Metastasis (Metastasis) 02/2015 - 10/2011
2	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 08/2011
2	Fanconi Anemia (Fanconi's Anemia) 03/2012 - 12/2008
2	Glioma (Gliomas) 11/2006 - 11/2002
2	Carcinoma (Carcinomatosis) 07/2005 - 01/2004
2	Radiation Injuries (Radiation Sickness) 07/2005 - 01/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Melanoma (Melanoma, Malignant) 02/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Weight Loss (Weight Reduction) 01/2013
1	Hyperplasia 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 10/2012
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 10/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2012
1	Lung Injury 10/2011
1	Vitamin A Deficiency 10/2011
1	Pneumonia (Pneumonitis) 10/2011
1	Edema (Dropsy) 08/2011
1	Hematoma 02/2010
1	Hematologic Neoplasms (Hematological Malignancy) 01/2010
1	Margins of Excision 05/2009
1	Necrosis 05/2009
1	Neoplasm Micrometastasis 05/2009
1	Rhabdomyosarcoma 09/2005
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2005
1	Infections 01/2005
1	Hyperthermia 11/2002

Drug/Important Bio-Agent (IBA)

7	Oxygen (Dioxygen)IBA 12/2017 - 11/2002
4	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 12/2008
4	Cytotoxins (Cytolysins)IBA 02/2013 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 02/2015 - 08/2002
3	Antineoplastic Agents (Antineoplastics)IBA 02/2013 - 11/2002
3	Hemoglobins (Hemoglobin)IBA 03/2006 - 01/2004
2	FenbendazoleIBA 02/2013 - 03/2012
2	1,2- bis(methylsulfonyl)- 1- - (2- chloroethyl)- 2- ((1- (4- nitrophenyl)ethoxy)carbonyl)hydrazineIBA 09/2012 - 06/2005
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2008 - 01/2005
2	efaproxiral (RSR-13)IBA 03/2006 - 01/2004
2	Carboplatin (JM8)FDA LinkGeneric 03/2006 - 01/2004
2	motexafin gadoliniumIBA 07/2005 - 04/2004
2	SolutionsIBA 04/2004 - 10/2002
1	fluoromisonidazoleIBA 12/2017
1	IntegrinsIBA 02/2015
1	ChitinasesIBA 02/2015
1	plexinIBA 02/2015
1	Semaphorins (Semaphorin)IBA 02/2015
1	MethyltransferasesIBA 03/2014
1	Taxoids (Taxanes)IBA 02/2013
1	PHY 906IBA 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012
1	Antinuclear AntibodiesIBA 10/2012
1	AutoantibodiesIBA 10/2012
1	Alkylating AgentsIBA 09/2012
1	laromustine (VNP40101M)IBA 03/2012
1	TransferasesIBA 03/2012
1	Vitamin A (Retinol)FDA LinkGeneric 10/2011
1	DepsipeptidesIBA 01/2010
1	plitidepsin (aplidine)IBA 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2008
1	DeoxyguanosineIBA 12/2008
1	NucleosidesIBA 12/2008
1	Indicators and Reagents (Reagents)IBA 11/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2005
1	Glutathione (Reduced Glutathione)IBA 07/2005
1	1,2- bis(methylsulfonyl)- 1- (2- chloroethyl)hydrazineIBA 06/2005
1	ProdrugsIBA 06/2005
1	Sulfhydryl Compounds (Thiols)IBA 06/2005
1	Plant ExtractsIBA 04/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2005
1	PorfiromycinIBA 01/2005
1	CytokinesIBA 01/2005
1	Mannitol (Osmitrol)FDA LinkGeneric 04/2004
1	MetalsIBA 04/2004
1	texaphyrinIBA 04/2004
1	Polystyrenes (Polystyrene)IBA 01/2004
1	SaltsIBA 01/2004
1	Cisplatin (Platino)FDA LinkGeneric 01/2004
1	AcidsIBA 01/2004
1	trichostatin A (A 300)IBA 05/2003
1	Histones (Histone)IBA 05/2003
1	Histone Deacetylase InhibitorsIBA 05/2003
1	Messenger RNA (mRNA)IBA 05/2003
1	Dihydrotachysterol (AT 10)IBA 02/2003
1	EnzymesIBA 02/2003
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 02/2003
1	Tumor Viral Antigens (Large T Antigen)IBA 02/2003
1	mitomycin C-DNA adductIBA 02/2003
1	DNA AdductsIBA 11/2002
1	PowdersIBA 10/2002
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2002
1	Bovine Serum AlbuminIBA 10/2002

Therapy/Procedure

8	Therapeutics 02/2013 - 11/2002
7	Radiotherapy 12/2017 - 01/2004
3	Drug Therapy (Chemotherapy) 03/2014 - 11/2002
3	Brachytherapy 08/2011 - 01/2004
2	Aftercare (After-Treatment) 03/2014 - 01/2004
1	Complementary Therapies (Alternative Medicine) 01/2013
1	Subcutaneous Injections 02/2010